
|Videos|October 24, 2015
Controlled Substance Red Flags
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
Advertisement
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some red flags related to prescriptions that can lead to administrative action from the DEA.
This video was recorded at the 2015 NCPA Annual Convention.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Addressing Drug Resistance in Lung Cancer
5